share_log

东曜药业-B(01875)一季度实现净利润约740.9万元 同比扭亏为盈

Dongyao Pharmaceutical-B (01875) achieved net profit of about 7.409 million yuan in the first quarter, turning a year-on-year loss into profit

Zhitong Finance ·  May 10 21:56

According to the Zhitong Finance App, Dongyao Pharmaceutical-B (01875) announced its results for the first quarter of 2024. Operating revenue increased 68% year on year to about 223 million yuan, and net profit was about 7.409 million yuan, turning a year-on-year loss into a profit.

According to the announcement, revenue growth was mainly due to a sharp increase in sales of self-developed products and continued growth in the CDMO/CMO business.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment